162 related articles for article (PubMed ID: 25998504)
1. Synthesis and antiproliferative activity of some novel benzo-fused imidazo[1,8]naphthyridinones.
Giannouli V; Kostakis IK; Pouli N; Marakos P; Samara P; Tsitsilonis O
Bioorg Med Chem Lett; 2015 Jul; 25(13):2621-3. PubMed ID: 25998504
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of novel amino-substituted xanthenones and benzo[b]xanthenones: evaluation of their antiproliferative activity and their ability to overcome multidrug resistance toward MES-SA/D x 5 cells.
Kostakis IK; Pouli N; Marakos P; Skaltsounis AL; Pratsinis H; Kletsas D
Bioorg Med Chem; 2006 May; 14(9):2910-34. PubMed ID: 16376546
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, antiproliferative activity and tubulin targeting effect of acridinone and dioxophenothiazine derivatives.
Verones V; Flouquet N; Lecoeur M; Lemoine A; Farce A; Baldeyrou B; Mahieu C; Wattez N; Lansiaux A; Goossens JF; Berthelot P; Lebegue N
Eur J Med Chem; 2013 Jan; 59():39-47. PubMed ID: 23202849
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide releasing acridone carboxamide derivatives as reverters of doxorubicin resistance in MCF7/Dx cancer cells.
Rajendra Prasad VV; Deepak Reddy G; Kathmann I; Amareswararao M; Peters GJ
Bioorg Chem; 2016 Feb; 64():51-8. PubMed ID: 26657603
[TBL] [Abstract][Full Text] [Related]
5. Exploring the anticancer potential of pyrazolo[1,2-a]benzo[1,2,3,4]tetrazin-3-one derivatives: the effect on apoptosis induction, cell cycle and proliferation.
Mingoia F; Di Sano C; Di Blasi F; Fazzari M; Martorana A; Almerico AM; Lauria A
Eur J Med Chem; 2013 Jun; 64():345-56. PubMed ID: 23644217
[TBL] [Abstract][Full Text] [Related]
6. 1-Methyl-3H-pyrazolo[1,2-a]benzo[1,2,3,4]tetrazin-3-ones. Design, synthesis, and biological activity of new antitumor agents.
Almerico AM; Mingoia F; Diana P; Barraja P; Lauria A; Montalbano A; Cirrincione G; Dattolo G
J Med Chem; 2005 Apr; 48(8):2859-66. PubMed ID: 15828824
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxicity studies of some novel fluoro acridone derivatives against sensitive and resistant cancer cell lines and their mechanistic studies.
Rajendra Prasad VV; Peters GJ; Lemos C; Kathmann I; Mayur YC
Eur J Pharm Sci; 2011 Jul; 43(4):217-24. PubMed ID: 21565270
[TBL] [Abstract][Full Text] [Related]
8. Molecular design, synthesis and biological research of novel pyridyl acridones as potent DNA-binding and apoptosis-inducing agents.
Zhang B; Chen K; Wang N; Gao C; Sun Q; Li L; Chen Y; Tan C; Liu H; Jiang Y
Eur J Med Chem; 2015 Mar; 93():214-26. PubMed ID: 25686590
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of quinazolinone tagged acridones as cytotoxic agents and their effects on EGFR tyrosine kinase.
Babu YR; Bhagavanraju M; Reddy GD; Peters GJ; Prasad VV
Arch Pharm (Weinheim); 2014 Sep; 347(9):624-34. PubMed ID: 24866341
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and antiproliferative activity of novel aminosubstituted benzothiopyranoisoindoles.
Christodoulou A; Kostakis IK; Kourafalos V; Pouli N; Marakos P; Trougakos IP; Tsitsilonis OE
Bioorg Med Chem Lett; 2011 May; 21(10):3110-2. PubMed ID: 21444205
[TBL] [Abstract][Full Text] [Related]
11. Dual-acting agents that possess reversing resistance and anticancer activities: Design, synthesis, MES-SA/Dx5 cell assay, and SAR of Benzyl 1,2,3,5,11,11a-hexahydro-3,3-dimethyl-1-oxo-6H-imidazo[3',4':1,2]pyridin[3,4-b]indol-2-substitutedacetates.
Liu J; Cui G; Zhao M; Cui C; Ju J; Peng S
Bioorg Med Chem; 2007 Dec; 15(24):7773-88. PubMed ID: 17888666
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, biological evaluation, molecular docking and QSAR studies of 2,4-dimethylacridones as anticancer agents.
Murahari M; Kharkar PS; Lonikar N; Mayur YC
Eur J Med Chem; 2017 Apr; 130():154-170. PubMed ID: 28246041
[TBL] [Abstract][Full Text] [Related]
13. Design and syntheses of permethyl ningalin B analogues: potent multidrug resistance (MDR) reversal agents of cancer cells.
Zhang PY; Wong IL; Yan CS; Zhang XY; Jiang T; Chow LM; Wan SB
J Med Chem; 2010 Jul; 53(14):5108-20. PubMed ID: 20560605
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antiproliferative activity of 4-substituted-piperazine-1-carbodithioate derivatives of 2,4-diaminoquinazoline.
Cao SL; Han Y; Yuan CZ; Wang Y; Xiahou ZK; Liao J; Gao RT; Mao BB; Zhao BL; Li ZF; Xu X
Eur J Med Chem; 2013 Jun; 64():401-9. PubMed ID: 23665106
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic and multidrug resistance reversal activities of novel 1,4-dihydropyridines against human cancer cells.
Shekari F; Sadeghpour H; Javidnia K; Saso L; Nazari F; Firuzi O; Miri R
Eur J Pharmacol; 2015 Jan; 746():233-44. PubMed ID: 25445037
[TBL] [Abstract][Full Text] [Related]
16. Acridone-pyrimidine hybrids- design, synthesis, cytotoxicity studies in resistant and sensitive cancer cells and molecular docking studies.
Murahari M; Prakash KV; Peters GJ; Mayur YC
Eur J Med Chem; 2017 Oct; 139():961-981. PubMed ID: 28886509
[TBL] [Abstract][Full Text] [Related]
17. Exploring epidermal growth factor receptor (EGFR) inhibitor features: the role of fused dioxygenated rings on the quinazoline scaffold.
Chilin A; Conconi MT; Marzaro G; Guiotto A; Urbani L; Tonus F; Parnigotto P
J Med Chem; 2010 Feb; 53(4):1862-6. PubMed ID: 20095624
[TBL] [Abstract][Full Text] [Related]
18. Multidrug resistance reversal activity of permethyl ningalin B amide derivatives.
Tao H; Hwang I; Boger DL
Bioorg Med Chem Lett; 2004 Dec; 14(24):5979-81. PubMed ID: 15546712
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and potent antileukemic activities of 10-benzyl-9(10H)-acridinones.
Gao C; Jiang Y; Tan C; Zu X; Liu H; Cao D
Bioorg Med Chem; 2008 Sep; 16(18):8670-5. PubMed ID: 18713666
[TBL] [Abstract][Full Text] [Related]
20. Natural tetraponerines: a general synthesis and antiproliferative activity.
Bosque I; Gonzalez-Gomez JC; Loza MI; Brea J
J Org Chem; 2014 May; 79(9):3982-91. PubMed ID: 24731136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
